Cellular and genetic mechanisms of self tolerance and autoimmunity

Nature

Volumn 435, Issue 7042, 2005, Pages 590-597

  Goodnow, Christopher C ^a   Sprent, Jonathon ^b   De St Groth, Barbara Fazekas ^c   Vinuesa, Carola G ^a  

^a Biology and Environment   (Australia)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c CENTENARY INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASES; HUMAN ENGINEERING; IMMUNOLOGY; NATURAL SCIENCES; PROTEINS;

AUTOIMMUNE DISEASES; CELLULAR MECHANISMS; IMMUNE SYSTEMS; SELF-TOLERANCE MECHANISMS;

GENES;

AUTOANTIBODY; AUTOIMMUNE REGULATOR PROTEIN; B LYMPHOCYTE RECEPTOR; BIM PROTEIN; CD28 ANTIGEN; CD40 LIGAND; CD5 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DNA; DNA METHYLTRANSFERASE; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 21; INTERLEUKIN 7; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN KINASE ZAP 70; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; LYMPHOCYTE ANTIGEN RECEPTOR;

MEDICINE;

AUTOIMMUNITY; B LYMPHOCYTE; CLONAL ANERGY; GENE MUTATION; GENOME; HUMAN; IMMUNOGENETICS; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN STRUCTURE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; CYTOLOGY; GENETICS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM;

ANIMALIA; MAMMALIA;

ANIMALS; AUTOIMMUNITY; CLONAL ANERGY; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTES; RECEPTORS, ANTIGEN;

EID: 20444485767     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03724     Document Type: Review

References (100)

1. Ignatowicz, L., Kappler, J. & Marrack, P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84, 521-529 (1996).
2. Zerrahn, J., Held, W. & Raulet, D. H. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88, 627-636 (1997).
3. Laufer, T. M., DeKoning, J., Markowitz, J. S., Lo, D. & Glimcher, L. H. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383, 81-85 (1996).
4. Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374-1377 (2003).
5. Jacobson, D. L., Gange, S. J., Rose, N. R. & Graham, N. M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immumpathol. 84, 223-243 (1997).
6. Nemazee, D. & Hogquist, K. A. Antigen receptor selection by editing or downregulation of V(D)J recombination. Curr. Opin. Immunol. 15, 182-189 (2003).
7. Healy, J. I. & Goodnow, C. C. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16, 645-670 (1998).
8. Schwartz, R. H. T cell anergy. Annu. Rev. Immunol. 21, 305-334 (2003).
9. Grossman, Z. & Paul, W. E. Self-tolerance: context-dependent tuning of T cell antigen recognition. Semin. Immunol. 12, 197-203 (2000).
10. Hartley, S. B. et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72, 325-335 (1993).
11. Fields, M. L. & Erikson, J. The regulation of lupus-associated autoantibodies: immunoglobulin transgenic models. Curr. Opin. Immunol. 15, 709-717 (2003).
12. Mackay, F., Schneider, P., Rennert, P. & Browning, J. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21, 231-264 (2003).
13. Jankovic, M., Casellas, R., Yannoutsos, N., Wardemann, H. & Nussenzweig, M. C. RAGs and regulation of autoantibodies. Annu. Rev. Immunol. 22, 485-501 (2004).
14. Strasser, A. & Bouillet, P. The control of apoptosis in lymphocyte selection. Immunol. Rev. 193, 82-92 (2003).
15. Akkaraju, S., Canaan, K. & Goodnow, C. C. Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells. J. Exp. Med. 186, 2005-2012 (1997).
16. Palmer, E. Negative selection - clearing out the bad apples from the T-cell repertoire. Nature Rev. Immunol. 3, 383-391 (2003).
17. Gao, J. X. et al. Perinatal blockade of B7-1 and B7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells. J. Exp. Med. 195, 959-971 (2002).
18. Kanagawa, O., Martin, S. M., Vaupel, B. A., Carrasco-Marin, E.& Unanue, E. R. Autoreactivity of T cells from nonobese diabetic mice: an I-Ag7-dependent reaction. Proc. Natl Acad Sci. USA 95, 1721-1724 (1998).
19. Wicker, L. S., Todd, J. A. & Peterson, L. B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179-200 (1995).
20. Salomon, B. et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194, 677-684 (2001).
21. Nagamine, K. et al. Positional cloning of the APECED gene. Nature Genet. 17, 393-398 (1997).
22. Aaltonen, J. et al. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genet. 17, 399-403 (1997).
23. Ramsey, C. et al. Aire-deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11, 397-409 (2002).
24. Anderson, M. S. et al. Projection of an immunological self-shadow within the thymus by the Aire protein. Science 298, 1395-1403 (2002).
25. Liston, A., Lesage, S., Wilson, J., Peltonen, L. & Goodnow, C. C. Aire regulates negative selection of organ-specific T cells. Nature Immunol. 4, 350-354 (2003).
26. Liston, A. et al. Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity J. Exp. Med. 200, 1015-1026 (2004).
27. Hanahan, D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10, 656-662 (1998).
28. Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet. 15, 293-297 (1997).
29. Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nature Genet. 15, 289-292 (1997).
30. Shiono, H. et al. Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann. NY Acad. Sci. 998, 237-256 (2003).
31. Sakaguchi, N. et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426, 454-460 (2003).
32. Gong, Q. et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nature Immunol. 2, 29-36 (2001).
33. McCarty, N. et al. Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes. Nature Immunol. 6, 65-72 (2005).
34. Rathmell, J. C., Lindsten, T., Zong, W. X., Cinalli, R. M. & Thompson, C. B. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nature Immunol. 3, 932-939 (2002).
35. Zhou, T. et al. Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J. Exp. Med. 183, 1879-1892 (1996).
36. Liston, A. et al. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21, 817-830 (2004).
37. Kishimoto, H. & Sprent, J. A defect in central tolerance in NOD mice. Nature Immunol. 2, 1025-1031 (2001).
38. Lesage, S. et al. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196, 1175-1188 (2002).
39. Choisy-Rossi, C. M., Holl, T. M., Pierce, M. A., Chapman, H. D. & Serreze, D. V. Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience. J. Immunol. 173, 3791-3800 (2004).
40. Kane, L. P., Lin, J. & Weiss, A. It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol. 23, 413-420 (2002).
41. Sprent, J. & Kishimoto, H. The thymus and negative selection. Immunol. Rev. 185, 126-135 (2002).
42. Villunger, A. et al. Negative selection of semimature CD4(+)8(-)HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc. Natl Acad. Sci. USA 101, 7052-7057 (2004).
43. Nagata, S. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J. Hum. Genet. 43, 2-8 (1998).
44. Benschop, R. J. et al. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity 14, 33-43 (2001).
45. Bell, S. E. & Goodnow, C. C. A selective defect in IgM antigen receptor synthesis and transport causes loss of cell surface IgM expression on tolerant B lymphocytes. EMBO J. 13, 816-826 (1994).
46. Lesley, R. et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 20, 441-453 (2004).
47. Rui, L., Vinuesa, C. G., Blasioli, J. & Goodnow, C. C. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nature Immunol. 4, 594-600 (2003).
48. Ravetch, J. V. & Lanier, L. L. Immune inhibitory receptors. Science 290, 84-89 (2000).
49. Hippen, K. L., Tze, L. E. & Behrens, T. W. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191, 883-890 (2000).
50. Wong, P., Barton, G. M., Forbush, K. A. & Rudensky, A. Y. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands J. Exp. Med. 193, 1179-1187 (2001).
51. Smith, K. et al. Sensory adaptation in naive peripheral CD4 T cells. J. Exp. Med. 194, 1253-1261 (2001).
52. Sharpe, A. H. & Freeman, G. J. The B7-CD28 superfamily. Nature Rev. Immunol. 2, 116-126 (2002).
53. Walker, L. S. & Abbas, A. K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nature Rev. Immunol. 2, 11-19 (2002).
54. + T cell proliferation and cytokine production but is not required for tuning T cell reactivity in adaptive tolerance. J. Immunol. 173, 7239-7248 (2004).
55. Ueda, H. et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511 (2003).
56. Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature Immunol. 5, 255-265 (2004)
57. + T cells. Immunity 18, 535-547 (2003)
58. Jeon, M. S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167-177 (2004).
59. Naramura, M. et al. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nature Immunol. 3, 1192-1199 (2002).
60. Liu, Y. C. Ubiquitin ligases and the immune response. Annu. Rev. Immunol. 22, 81-127 (2004).
61. Yokoi, N. et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nature Genet. 31, 391-394 (2002).
62. Cyster, J. G., Hartley, S. B. & Goodnow, C. C. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature 371, 389-395 (1994).
63. Thien, M. et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20, 785-798 (2004).
64. Claudio, E., Brown, K., Park, S., Wang, H. & Siebenlist, U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nature Immunol. 3, 958-965 (2002).
65. Xu, L. G., Wu, M., Hu, J., Zhai, Z. & Shu, H. B. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukoc. Biol. 72, 410-416 (2002).
66. Fox, C. J. et al. Theserine/threonine kinase Pim-2 isatranscriptionally regulated apoptotic inhibitor. Genes Dev. 17, 1841-1854 (2003).
67. Sprent, J. & Surh, C. D. T cell memory. Annu. Rev. Immunol. 20, 551-579 (2002).
68. Marrack, P. & Kappler, J. Control of T cell viability. Annu. Rev. Immunol. 22, 765-787 (2004).
69. Barthlott, T., Kassiotis, G. & Stockinger, B. T cell regulation as a side effect of homeostasis and competition. J. Exp. Med. 197, 451-460 (2003).
70. Le Deist, F., Poinsignon, C., Moshous, D., Fischer, A. & de Villartay, J. P. Artemis sheds new light on V(D)J recombination. Immunol. Rev. 200, 142-155 (2004).
71. Dupuis-Girod, S. et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111, e622-e627 (2003).
72. Coles, A. J. et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiplesclerosis. Lancet 354, 1691-1695 (1999).
73. MacMurray, A. J. et al. Lymphopenia in the BB rat model of type 1 diabetes is dueto a mutation in a novel immune-associated nucleotide (lan)-related gene. Genome Res. 12, 1029-1039 (2002).
74. Hornum, L., Romer, J. & Markholst, H. The diabetes-prone BB rat carries a frameshift mutation in lan4, a positional candidate of lddm1. Diabetes 51, 1972-1979 (2002).
75. King, C., Ilic, A., Koelsch, K. & Sarvetnick, N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117, 265-277 (2004).
76. Foy, T. M., Aruffo, A., Bajorath, J., Buhlmann, J. E. & Noelle, R. J. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14, 591-617 (1996).
77. Kovanen, P. E. & Leonard, W. J. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2,4,7,9,15, and 21, and their signaling pathways. Immunol. Rev. 202, 67-83 (2004).
78. Ang, C. W., Jacobs, B. C. & Laman, J. D. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol. 25, 61-66 (2004).
79. Beutler, B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430, 257-263 (2004).
80. Leadbetter, E. A. et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002).
81. Richardson, B. DNA methylation and autoimmune disease. Clin. Immunol. 109, 72-79 (2003).
82. Taylor, P. R. et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192, 59-366 (2000).
83. Radic, M. Z. & Weigert, M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12, 487-520 (1994).
84. Ray, S. K., Putterman, C. & Diamond, B. Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc. Natl Acad. Sci. USA 93, 2019-2024 (1996).
85. Slifka, M. K., Antia, R., Whitmire, J. K. & Ahmed, R. Humoral immunity due to long-lived plasma cells. Immunity 8, 363-372 (1998).
86. Rosen, A. & Casciola-Rosen, L. Clearing the way to mechanisms of autoimmunity. Nature Med. 7, 664-665 (2001).
87. Weyand, C. M., Kurtin, P. J. & Goronzy, J. J. Ectopic lymphoid organogenesis: a fast track for autoimmunity. Am. J. Pathol. 159, 787-793 (2001).
88. Mandik-Nayak, L., Wipke, B. T., Shih, F. F., Unanue, E. R. & Allen, P. M. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc. Natl Acad. Sci. USA 99, 14368-14373 (2002).
89. Reif, K. et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 416, 94-99 (2002).
90. Shokat, K. M. & Goodnow, C. C. Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375, 334-338 (1995).
91. Pulendran, B., Kannourakis, G., Nouri, S., Smith, K. G. & Nossal, G. J. Soluble antigen can cause enhanced apoptosis of germinal-centre B cells. Nature 375, 331-334 (1995).
92. Han, S. et al. Cellular interaction in germinal centers: roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155, 556-567 (1995).
93. Kroczek, R. A., Mages, H. W. & Hutloff, A. Emerging paradigms of T-cell co-stimulation. Curr. Opin. Immunol. 16, 321-327 (2004).
94. Walker, L. S., Gulbranson-Judge, A., Flynn, S., Brocker, T. & Lane, P. J. Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol. Today 21, 333-337 (2000).
95. Crotty, S., Kersh, E. N., Cannons, J., Schwartzberg, P. L. & Ahmed, R. SAP is required for generating long-term humoral immunity. Nature 421, 282-287 (2003).
96. Kearney, E. R., Pape, K. A., Loh, D. Y. & Jenkins, M. K. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo. Immunity 1, 327-339 (1994)
97. Vinuesa, C. G. et al. A novel RING-type ubiquitin ligase family member essential to repress follicular helper T cells and autoimmunity. Nature doi:10.1038/nature03555 (this issue).
98. Scofield, R. H. Autoantibodies as predictors of disease. Lancet 363, 1544-1546 (2004).
99. Wipke, B. T., Wang, Z., Nagengast, W., Reichert, D. E. & Allen, P. M. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J. Immunol. 172, 7694-7702 (2004).
100. Wonach, P. A., Benoist, C. & Mathis, D. The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv. Immunol. 82, 217-248 (2004).